Should active CMV retinitis in non-immunocompromised newborn babies be treated?

Br J Ophthalmol. 2002 Feb;86(2):248-9. doi: 10.1136/bjo.86.2.248.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus Retinitis / congenital*
  • Cytomegalovirus Retinitis / drug therapy
  • Follow-Up Studies
  • Ganciclovir / therapeutic use*
  • Humans
  • Immunocompetence
  • Infant, Newborn
  • Male

Substances

  • Antiviral Agents
  • Ganciclovir